Pharma Mar Balance Sheet Health
Financial Health criteria checks 4/6
Pharma Mar has a total shareholder equity of €193.4M and total debt of €39.9M, which brings its debt-to-equity ratio to 20.6%. Its total assets and total liabilities are €340.5M and €147.1M respectively.
Key information
20.6%
Debt to equity ratio
€39.86m
Debt
Interest coverage ratio | n/a |
Cash | €162.56m |
Equity | €193.44m |
Total liabilities | €147.08m |
Total assets | €340.52m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PMRA's short term assets (€252.6M) exceed its short term liabilities (€95.9M).
Long Term Liabilities: PMRA's short term assets (€252.6M) exceed its long term liabilities (€51.2M).
Debt to Equity History and Analysis
Debt Level: PMRA has more cash than its total debt.
Reducing Debt: PMRA's debt to equity ratio has reduced from 534.6% to 20.6% over the past 5 years.
Debt Coverage: PMRA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if PMRA's interest payments on its debt are well covered by EBIT.